Education
About Us
Working with TipRanks
Follow Us
Tenon Medical, Inc. (TNON)
NASDAQ:TNON
TNON Stock Chart & Stats
$1.11
-$0.13(-5.94%)
At close: 4:00 PM EST
$1.11
-$0.13(-5.94%)
Day’s Range― - ―
52-Week Range$0.85 - $5.85
Previous CloseN/A
Volume74.29K
Average Volume (3M)189.55K
Market Cap
$10.39M
Enterprise Value$3.62M
Total Cash (Recent Filing)$3.44M
Total Debt (Recent Filing)$216.00K
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Mar 05, 2026EPS Estimate
-0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding8,879,220
10 Day Avg. Volume240,436
30 Day Avg. Volume189,548
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.38
Price to Sales (P/S)0.70
P/FCF Ratio-0.23
Enterprise Value/Market Cap0.35
Enterprise Value/Revenue1.12
Enterprise Value/Gross Profit2.13
Enterprise Value/Ebitda-0.29
Forecast
1Y Price Target
$2.75Price Target Upside147.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Innovation And Product LaunchThe company is expected to initiate a pilot launch of SImmetry+ in 4Q25, with a broader commercial rollout planned for 2026, highlighting ongoing commitment to innovation.
Revenue GrowthThe company reported record revenue in 3Q25, supported by the highest Catamaran procedure volume to date and the initial contribution from SImmetry+.
Strategic AcquisitionsThe acquisition of sacroiliac (SI) joint-specific assets from SiVantage broadens Tenon Medical's SI joint fusion portfolio and strengthens its competitive positioning.
Bears Say
Higher Operating ExpensesThe GAAP loss per share was slightly wider than consensus due to higher-than-expected operating expenses, elevated by integration costs from the acquisition of SiVantage SImmetry.
Revenue EstimatesRevenue for 2Q25 was below consensus, and 2025 and 2026 revenue estimates have been lowered due to recalibration.
Tenon Medical, Inc. News
TNON FAQ
What was Tenon Medical, Inc.’s price range in the past 12 months?
Tenon Medical, Inc. lowest stock price was $0.85 and its highest was $5.85 in the past 12 months.
What is Tenon Medical, Inc.’s market cap?
Tenon Medical, Inc.’s market cap is $10.39M.
When is Tenon Medical, Inc.’s upcoming earnings report date?
Tenon Medical, Inc.’s upcoming earnings report date is Mar 05, 2026 which is in 91 days.
How were Tenon Medical, Inc.’s earnings last quarter?
Tenon Medical, Inc. released its earnings results on Nov 13, 2025. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.37 by -$0.03.
Is Tenon Medical, Inc. overvalued?
According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued.
Does Tenon Medical, Inc. pay dividends?
Tenon Medical, Inc. does not currently pay dividends.
What is Tenon Medical, Inc.’s EPS estimate?
Tenon Medical, Inc.’s EPS estimate is -0.36.
How many shares outstanding does Tenon Medical, Inc. have?
Tenon Medical, Inc. has 8,879,220 shares outstanding.
What happened to Tenon Medical, Inc.’s price movement after its last earnings report?
Tenon Medical, Inc. reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.37. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Tenon Medical, Inc.?
Currently, no hedge funds are holding shares in TNON
Company Description
Tenon Medical, Inc.
Tenon Medical, Inc. (TNON) is a medical device company focused on developing innovative solutions for the treatment of spinal conditions. The company operates primarily in the healthcare sector, specializing in minimally invasive surgical products designed to enhance patient outcomes and streamline surgical procedures. Tenon Medical's core offerings include advanced spinal implants and instrumentation aimed at addressing complex spinal disorders, catering to both surgeons and patients through their state-of-the-art technology and design.
TNON Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects strong operational and strategic progress with record revenue growth, successful integration of acquisitions, and key product launches. However, challenges persist with increased operating expenses and a notable net loss, although mitigated by improved gross profit margins and no outstanding debt.View all TNON earnings summariesTNON Stock 12 Month Forecast
Average Price Target
$2.75
▲(147.75% Upside)
Technical Analysis
Strata Skin Sciences
―
Lifeward
―
enVVeno Medical
―
PAVmed
―
Heart Test Laboratories, Inc.
―
Ownership Overview
4.85% Insiders
0.55% Mutual Funds
0.30% Other Institutional Investors
93.46% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---